Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
14M
-
Shares change
-
+119K
-
Total reported value, excl. options
-
$281M
-
Value change
-
+$4.79M
-
Number of buys
-
7
-
Number of sells
-
-13
-
Price
-
$20.10
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2016
28 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q3 2016.
Ascendis Pharma A/S - ADR (ASND) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14M shares
of 55.6M outstanding shares and own 25.18% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, LLC (3.68M shares), FMR LLC (2.51M shares), ORBIMED ADVISORS LLC (2.19M shares), Vivo Capital, LLC (1.77M shares), BAKER BROS. ADVISORS LP (746K shares), VHCP Management II, LLC (721K shares), JANUS CAPITAL MANAGEMENT LLC (648K shares), ACUTA CAPITAL PARTNERS, LLC (363K shares), Rock Springs Capital Management LP (300K shares), and SPHERA FUNDS MANAGEMENT LTD. (264K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.